- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
What We're Reading: ACA Premiums Rose 9%
What we're reading, January 22, 2016: the average premium under the Affordable Care Act rose to $408 before tax credits; seniors will face higher Medicare Advantage premiums with a merge between Aetna and Humana; and Hawaii could be the first state to offer long-term care benefits.
Before taking into account tax credits that lower premiums, the average premium under the Affordable Care Act is $408 per month for 2016, which is a 9% increase. However, after tax credits, the average premium enrollees pay is $118, according to The Hill. As the premium level rose, so did the financial assistance from the government, increasing from an average of $268 for 2015 plans to $294 for 2016 plans.
Meanwhile, seniors will face higher Medicare Advantage premiums if Aetna’s proposal to buy Humana is approved by regulators. Reuters reported that Aetna premiums were at least $155 less annually and up to $305 lower annually in counties where it competed with Humana. Aetna has said that beneficiaries who are facing a premium increase in Medicare Advantage could always switch to traditional Medicare.
In Hawaii, seniors could become the first in the country to have access to long-term care benefits. Lawmakers are introducing a bill that would provide seniors with a benefit of $70 per day for 1 year, which could be used to pay family caregivers, hire in-home aids, and help offset the cost of safety equipment, according to The Washington Post. Hawaii would cover the cost of the benefit through a 0.5% increase in the state’s general excise tax.
"The Barriers Are Real": Antoine Keller, MD, on Geography and Cardiovascular Health
April 18th 2025Health care disparities are often driven by where patients live, explained Antoine Keller, MD, as he discussed the complex, systematic hurdles that influence the health of rural communities.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More
